Student Name
Capella University
NURS-FPX4905 Capstone Project for Nursing
Prof. Name
Date
Intervention Proposal
The Longevity Center is a specialized clinical organization focused on preventive and regenerative medicine. Services include hormone optimization, advanced biomarker analysis, and cellular-based therapies. The center caters mainly to individuals seeking proactive, personalized health management. However, operational inefficiencies have caused delays in diagnostic clarification, particularly for patients with multifactorial or ambiguous symptoms. In regenerative medicine, late detection of hormonal imbalances, inflammation, autoimmune triggers, or micronutrient deficiencies can compromise therapeutic effectiveness and patient outcomes (Sierra et al., 2021).
This proposal outlines a structured, systems-level improvement plan emphasizing workflow redesign and the implementation of a Clinical Decision Support System (CDSS). The goal is to enhance diagnostic speed, improve clinical accuracy, and embed evidence-informed regenerative practices throughout the patient care process.
Identification of the Practice Issue
What is the primary clinical problem affecting patient outcomes at The Longevity Center?
The main clinical challenge is the extended diagnostic turnaround for patients presenting with complex or nonspecific symptoms. These delays hinder timely initiation of regenerative therapies, including peptide protocols, bioidentical hormone replacement, platelet-rich plasma (PRP) injections, and stem-cell–based interventions. Given that regenerative treatments rely on early and precise biomarker identification, diagnostic inefficiencies negatively impact both treatment effectiveness and patient satisfaction (Sierra et al., 2021).
Which operational factors contribute to diagnostic delays?
An internal analysis identified several workflow limitations that exacerbate delays:
- Fragmented communication among interdisciplinary teams
- Absence of standardized triage and prioritization procedures
- Manual laboratory result interpretation without automated alerts
- Inconsistent documentation practices
These deficiencies introduce variability in care, increasing the risk of overlooked or delayed detection of clinically significant conditions. In a precision medicine setting, such inconsistencies directly affect therapeutic outcomes.
Current Practice
How are intake and diagnostic workflows currently structured?
Currently, patient intake relies on paper forms that are manually transcribed into the Electronic Health Record (EHR). This redundancy increases transcription errors and prolongs administrative processing. Laboratory results are reviewed manually by providers without automated notifications for critical or abnormal findings. Moreover, no CDSS tools are integrated into the EHR to assist clinicians with differential diagnosis or selection of regenerative protocols.
Table 1 outlines key operational gaps and their impact on regenerative care:
Table 1
Current Workflow Limitations
| Clinical Domain | Existing Process | Impact on Regenerative Care |
|---|---|---|
| Patient Intake | Paper forms manually entered into EHR | Increased documentation errors; slowed throughput |
| Laboratory Review | Manual interpretation without alerts | Delayed recognition of abnormal biomarkers |
| Clinical Decision Support | No CDSS integration | Inconsistent application of evidence-based protocols |
| Staff Workflow | Non-standardized processes | Variability in care timelines and treatment readiness |
The lack of standardized diagnostic algorithms contributes to variability in therapies such as hormone modulation, PRP treatments, and cellular rejuvenation protocols.
Proposed Strategy
What intervention is recommended to mitigate diagnostic inefficiencies?
The recommended intervention involves implementing a digital intake system integrated with the EHR, combined with CDSS deployment. This approach focuses on optimizing patient intake, automating laboratory surveillance, and providing evidence-based clinical decision support. By aligning technology with clinical workflows, the intervention is designed to enhance operational efficiency and patient outcomes (Wolfien et al., 2023).
What are the essential components of the intervention?
The intervention consists of:
- Development of standardized digital intake templates
- Provider and nursing education on workflow optimization
- Integration of CDSS functions for laboratory alerts and diagnostic guidance (Khalil et al., 2025)
- Scheduled interdisciplinary meetings to review CDSS alerts
- Phased pilot rollout to ensure workflow stability and refinement (Klein, 2025)
The CDSS will provide differential diagnosis support, monitor biomarker trends, and recommend treatments based on current regenerative medicine evidence.
Impact on Quality, Safety, and Cost
How will this intervention improve quality of care?
By standardizing intake and integrating automated decision support, the intervention reduces variability and strengthens adherence to evidence-based regenerative protocols. Improved biomarker monitoring enhances diagnostic accuracy and supports timely initiation of stem-cell and hormone-based therapies (Ghasroldasht et al., 2022).
How does the strategy enhance patient safety?
Automated alerts minimize the risk of missed abnormal lab values. Strengthened interdisciplinary communication reduces handoff errors, promoting safer administration of biologic and cellular therapies (White et al., 2023).
What financial implications are anticipated?
Early identification of imbalances can prevent costly emergencies and redundant testing. While the intervention requires initial technological investment, projected cost savings stem from enhanced efficiency and avoidance of high-cost acute care episodes.
Table 2
Projected Outcomes of CDSS Integration
| Domain | Expected Improvement | Regenerative Care Example |
|---|---|---|
| Quality | Greater diagnostic accuracy; fewer omissions | Early detection of micronutrient insufficiencies |
| Safety | Automated abnormal lab alerts | Prevention of untreated hormonal dysregulation |
| Cost | Reduced redundant testing and ER visits | Avoidance of $8,000–$15,000 acute care episodes |
Role of Technology
In what ways does technology enable sustainable improvement?
Technology serves as the core facilitator of this intervention. CDSS integration within the EHR offers real-time guidance, including lab flagging, differential diagnosis support, and protocol recommendations (Derksen et al., 2025). This reduces cognitive load on providers, enhances longitudinal biomarker monitoring, and promotes transparency across interdisciplinary teams. Ethical oversight ensures responsible data use and patient safety (Hermerén, 2021).
Implementation at Practicum Site
What is the implementation framework?
The intervention will follow a phased rollout, beginning with a pilot cohort of clinicians. Workflow mapping, simulation testing, and iterative refinement will precede organization-wide adoption (Klein, 2025).
What barriers are anticipated and how will they be mitigated?
| Anticipated Barrier | Mitigation Strategy |
|---|---|
| Staff resistance | Structured training and change management |
| Budget limitations | Phased licensing and academic partnerships |
| Technical integration challenges | Pre-implementation system testing and IT collaboration (Makhni & Hennekes, 2023) |
This phased approach reduces disruption while supporting sustainable adoption.
Interprofessional Collaboration
Which professional roles are integral to successful execution?
Effective CDSS integration requires coordinated contributions from multiple professional roles.
Table 3
Interprofessional Contributions
| Role | Primary Responsibility | Application in Regenerative Care |
|---|---|---|
| Nurses & Nurse Practitioners | Conduct comprehensive digital intake | Identify contraindications for PRP or peptide therapy |
| Physicians | Define diagnostic thresholds & algorithms | Determine eligibility for cellular interventions |
| IT Specialists | Configure and maintain EHR-CDSS | Set regenerative-specific biomarker alerts |
| Administrative Personnel | Manage training and compliance tracking | Organize interdisciplinary review sessions |
Collaborative governance ensures technology and clinical workflows are aligned.
Conclusion
Integrating standardized digital intake protocols with a Clinical Decision Support System provides a strategic advantage for The Longevity Center. By addressing diagnostic delays, improving workflow reliability, and embedding evidence-based regenerative guidance, the organization can enhance patient safety, optimize therapeutic outcomes, and maintain cost-effectiveness. A phased, interdisciplinary implementation ensures long-term success while advancing precision medicine practices.
References
Derksen, C., Walter, F. M., Akbar, A. B., Parmar, A. V. E., Saunders, T. S., Round, T., Rubin, G., & Scott, S. E. (2025). The implementation challenge of computerised clinical decision support systems for the detection of disease in primary care: Systematic review and recommendations. Implementation Science, 20, 1–33. https://doi.org/10.1186/s13012-025-01445-4
Ghasroldasht, M. M., Seok, J., Park, H.-S., Liakath Ali, F. B., & Al-Hendy, A. (2022). Stem cell therapy: From idea to clinical practice. International Journal of Molecular Sciences, 23(5). https://doi.org/10.3390/ijms23052850
NURS FPX 4905 Assessment 4 Intervention Proposal
Hermerén, G. (2021). The ethics of regenerative medicine. Biologia Futura, 72, 113–118. https://doi.org/10.1007/s42977-021-00075-3
Khalil, C., Saab, A., Rahme, J., Bouaud, J., & Seroussi, B. (2025). Capabilities of computerized decision support systems supporting the nursing process in hospital settings: A scoping review. BMC Nursing, 24(1). https://doi.org/10.1186/s12912-025-03272-w
Klein, N. J. (2025). Patient blood management through electronic health record [EHR] optimization (pp. 147–168). Springer Nature. https://doi.org/10.1007/978-3-031-81666-6_9
Makhni, E. C., & Hennekes, M. E. (2023). The use of patient-reported outcome measures in clinical practice and clinical decision making. The Journal of the American Academy of Orthopaedic Surgeons, 31(20), 1059–1066. https://doi.org/10.5435/JAAOS-D-23-00040
Sierra, Á., Kim, K. H., Morente, G., & Santiago, S. (2021). Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries. Regenerative Medicine, 6(1), 1–23. https://doi.org/10.1038/s41536-021-00144-0
NURS FPX 4905 Assessment 4 Intervention Proposal
White, N., Carter, H. E., Borg, D. N., Brain, D. C., Tariq, A., Abell, B., Blythe, R., & McPhail, S. M. (2023). Evaluating the costs and consequences of computerized clinical decision support systems in hospitals: A scoping review and recommendations for future practice. Journal of the American Medical Informatics Association, 30(6), 1205–1218. https://doi.org/10.1093/jamia/ocad040
Wolfien, M., Ahmadi, N., Fitzer, K., Grummt, S., Heine, K.-L., Jung, I.-C., Krefting, D., Kuhn, A. N., Peng, Y., Reinecke, I., Scheel, J., Schmidt, T., Schmücker, P., Schüttler, C., Waltemath, D., Zoch, M., & Sedlmayr, M. (2023). Ten topics to get started in medical informatics research. Journal of Medical Internet Research, 25. https://doi.org/10.2196/45948